Healthcare -
Biotechnology - NASDAQ - US
$ 0.188
2.68 %
$ 12.3 M
Market Cap
-0.13
P/E
LYRA - TOTAL CURRENT LIABILITIES
Total Current Liabilities LYRA - Lyra Therapeutics, Inc.
19.6 M
LAST VALUE
3.64%
2 YEAR CAGR
58.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR